Health Experts’ Perspectives on Barriers, Facilitators, and Needs for Improvement of Hospital Care in the Dying Phase
Kaur S, Boström K, Ullrich A, Oubaid N, Oechsle K, Schulz H, Voltz R, Kremeike K
INT J CLIN PRACT. 2024;2024:1012971.

Improving the dying situation on non-palliative care wards: Evaluation of the participants’ perspectives on a bottom-up approach
Milke V, Oubaid N, Schieferdecker A, Ullrich A, Schulz H, Kaur S, Meesters S, Kremeike K, Leminski C, Voltz R, Bokemeyer C, Oechsle K
2024. Oncology Research and Treatment. Büttner R (eds.). (Suppl. 1). ed. Köln: Karger, 174-175.

Angehörige - herausfordernd oder wertvolle Ressource?
Oechsle K
ONKOLOGIE-GER. 2024;30(Suppl 1):7–12.

Mitbetreuung der Angehörigen von Patient:innen mit einer nicht heilbaren Krebserkrankung im Erkrankungsverlauf
Oechsle K, Berendt J, Gebert T, Heckel M, Leopold H, Hornemann B, Jentschke E, Neukirchen M, van Oorschot B, Rechenmacher M, Schnabel A, Simon S, Stiel S, Ullrich A
ONKOLOGIE-GER. 2024;2024:1-8.

SOP - Mitbetreuung der Angehörigen von Patient:innen mit einer nicht heilbaren Krebserkrankung in der Sterbephase
Oechsle K, Berendt J, Gebert T, Heckel M, Leopold H, Hornemann B, Jentschke E, Neukirchen M, van Oorschot B, Rechenmacher M, Schnabel A, Simon S, Stiel S, Ullrich A
ONKOLOGIE-GER. 2024;2024:1-8.

74/m mit starken Schmerzen bei bekanntem metastasiertem Prostatakarzinom: Vorbereitung auf die Facharztprüfung. Fall 47
Oechsle K, Schieferdecker A, Coym A, Weidmann J
ONKOLOGIE-GER. 2024;30:329–334.

Mitbetreuung von Angehörigen in spezifischen Versorgungsformen und der Pandemie: Ein Überblick über neue Erkenntnisse aus der Forschung in Deutschland – Teil 2
Oechsle K, Strupp J, Doll A, Ullrich A, Stiel S
Z PALLIATMEDIZIN. 2024;25(5):224-228.

67/m mit dekompensierter häuslicher Versorgung unter Erstlinientherapie beim metastasiertem kleinzelligem Bronchialkarzinom: Vorbereitung auf die Facharztprüfung: Fall 49
Oechsle K, Stübig T, Coym A, Schieferdecker A, Weidmann J
ONKOLOGIE-GER. 2024;30:886–890.

Palliative-specific stressors for health care professionals on non-palliative care wards and comparison with palliative care wards
Oubaid N, Milke V, Schieferdecker A, Schulz H, Kaur S, Meesters S, Kremeike K, Leminski C, Voltz R, Bokemeyer C, Oechsle K
2024. Oncology Research and Treatment : 36. Deutscher Krebskongress Fortschritt gemeinsam gestalten. Köln: Karger, 173.

Bedürfnisse, Probleme und Bedarfe von Angehörigen in der Palliativversorgung: Ein Überblick über neue Erkenntnisse aus der Forschung in Deutschland - Teil 1
Stiel S, Oechsle K, Doll A, Strupp J, Herbst F, Ullrich A
Z PALLIATMEDIZIN. 2024;25(4):172-175.

"Being an informal caregiver - strengthening resources"
Theißen T, Ullrich A, Oechsle K, Wikert J, Bokemeyer C, Schieferdecker A
BMC PALLIAT CARE. 2024;23(1):95.

"Being an informal caregiver - strengthening resources": mixed methods evaluation of a psychoeducational intervention supporting informal caregivers in palliative care
Theißen T, Ullrich A, Oechsle K, Wikert J, Bokemeyer C, Schieferdecker A
BMC PALLIAT CARE. 2024;23(1):95.

Correction: "Being an informal caregiver - strengthening resources": mixed methods evaluation of a psychoeducational intervention supporting informal caregivers in palliative care
Theißen T, Ullrich A, Oechsle K, Wikert J, Bokemeyer C, Schieferdecker A
BMC PALLIAT CARE. 2024;23(1):113.

The CAREPAL-8: a short screening tool for multidimensional family caregiver burden in palliative care
Ullrich A, Bergelt C, Marx-Rosenberg G, Daubmann A, Benze G, Heine J, Dickel L, Wowretzko F, Zhang Y, Bokemeyer C, Nauck F, Oechsle K
BMC PALLIAT CARE. 2024;23(1):195.

Death anxiety in patients with advanced cancer and their family caregivers
Walbaum C, Philipp R, Bokemeyer C, Härter M, Junghans J, Koch-Gromus U, Oechsle K, Schilling G, Vehling S
J PAIN SYMPTOM MANAG. 2024;68(6):622-631.

Existential distress among family caregivers of patients with advanced cancer: A systematic review and meta-analysis
Walbaum C, Philipp R, Oechsle K, Ullrich A, Vehling S
PSYCHO-ONCOLOGY. 2024;33(1):e6239.

The OUTREACH study: oncologists of German university hospitals in rotation on a palliative care unit-evaluation of attitude and competence in palliative care and hospice
Biersching T, Schweda A, Oechsle K, Nauck F, Rosenbruch J, Schuler U, Hense J, Neukirchen M, Weber M, Junghanss C, Kramer T, Ostgathe C, Thuss-Patience P, van Oorschot B, Teufel M, Schuler M, Bausewein C, Tewes M
J CANCER RES CLIN. 2023;149(7):2929-2936.

Association between oncologists' death anxiety and their end-of-life communication with advanced cancer patients
Harnischfeger N, Rath H, Alt-Epping B, Brand H, Haller K, Letsch A, Rieder N, Thuss-Patience P, Bokemeyer C, Oechsle K, Bergelt C
PSYCHO-ONCOLOGY. 2023;32(6):923-932.

Wir sind Angehörige: die SORGEEINHEIT (care unit)
Heller A, Oechsle K
Praxis Palliative Care. 2023;(60):1.

SOP Akuter Verwirrtheitszustand und Delir in der Palliativmedizin
Jentschke E, Roch C, Reinholz U, Gahr S, Gärtner J, Lewerenz J, Mayer-Steinacker R, Oechsle K, Villalobos M
ONKOLOGIE-GER. 2023;2023(2):141-146.

"Wir sind alle Angehörige". Chancen und Risiken der Angehörigen-Perspektive
Menzel L, Oechsle K
Praxis Palliative Care. 2023;(60):24-25.

Angehörige in der Hospiz- und Palliativversorgung - Vernetzung von Forschung und Versorgungspraxis am Beispiel Hamburgs
Oechsle K
Die Hospiz-Zeitschrift: Fachforum für palliative Care. 2023;2023(3):11-15.

Angehörigen-Mitbetreuung: Wo stehen wir uns was brauchen wir?
Oechsle K
Praxis Palliative Care. 2023;2023(60):55-56.

Angehörige sterbenskranker Menschen in verschiedenen Versorgungsformen
Oechsle K
Public Health Forum. 2023;31(1):25-28.

Bedürfnisse und Betreuung von Angehörigen
Oechsle K
2023. Elsevier Essentials Palliativmedizin. Wedding U, Fuxius S (eds.). 1. ed. München: Elsevier GmbH, 23-27.

Die Doppelrolle der Angehörigen. Erkenntnisse der Angehörigenforschung
Oechsle K
Praxis Palliative Care. 2023;(60):27-29.

Forschung mit und für Angehörige: Universitätsprofessur für Palliativmedizin mit Schwerpunkt Angehörigenforschung in Hamburg
Oechsle K
Praxis Palliative Care. 2023;(60):26.

Palliativmedizin
Oechsle K
2023. Taschenbuch Hämatologie und Onkologie. Honecker F, Claßen J, Preiß J, Dornoff W (eds.). 21. ed. München: W. Zuckschwerdt Verlag, 302-307.

Schmerztherapie
Oechsle K
2023. Taschenbuch Hämatologie und Onkologie . Honecker F, Claßen J, Preiß J, Dornoff W (eds.). 21. ed. München: W. Zuckschwerdt Verlag, 299-301.

Ungehört und „ungehörig“? Angehörige in der Hospiz- und Palliativversorgung
Oechsle K
Bundes-Hospiz-Anzeiger: Palliativversorgung am Lebensende im deutschen Gesundheitswesen. 2023;21(3):6-7.

Wenn Versorgende selbst Betroffene werden - Rollenkonflikte und deren Folgen: eine sehr persönliche Erfahrung und fachliche Einordnung
Oechsle K
Z PALLIATMEDIZIN. 2023;24(01):8-11.

Praxismaterial: Angehörigen-Mitbetreuung "aus der Distanz". Möglichkeiten und Erfahrungen.
Oechsle K, Theißen T, Gebert T, Schieferdecker A, Weidmann J, Ullrich A
Praxis Palliative Care. 2023;(60):1-11.

Bedürfnisse und Belastungsfaktoren pflegender Angehöriger
Oechsle K, Ullrich A
2023. Palliative Care. Kern M, Gaspar M, Hach M (eds.). 1. ed. Stuttgart, New York: Thieme, 256-258.

Psychosoziale Belastungen und Unterstützungsbedürfnisse von Patient:innen in der Palliativversorgung
Oechsle K, Ullrich A
Onkologische Pflege. 2023;13(Sonderheft/2023):28-32.

Screening versus multidimensional assessment of symptoms and psychosocial distress in cancer patients from the time of incurability
Solar S, Wieditz J, Lordick F, Mehnert-Theuerkauf A, Oechsle K, van Oorschot B, Thomas M, Asendorf T, Nauck F, Alt-Epping B
FRONT ONCOL. 2023;13:1002499.

Symptom burden, psychosocial distress and palliative care needs in heart failure – A cross-sectional explorative pilot study
Strangl F, Ischanow E, Ullrich A, Oechsle K, Fluschnik N, Magnussen C, Knappe D, Grahn H, Blankenberg S, Bokemeyer C, Kirchhof P, Rybczynski M
CLIN RES CARDIOL. 2023;112(1):49-58.

Evaluation of a Routine Psychosocial Screening for Patients Receiving Inpatient Specialist Palliative Care: Feasibility and Outcomes
Ullrich A, Bahloul S, Bokemeyer C, Oechsle K
J SOC WORK END-LIFE. 2023;19(1):33-52.

Specialist palliative care until the very end of life - reports of family caregivers and the multiprofessional team
Ullrich A, Goldbach S, Hollburg W, Wagener B, Rommel A, Müller M, Kirsch D, Kopplin-Foertsch K, Schulz H, Bokemeyer C, Oechsle K
BMC PALLIAT CARE. 2023;22(1):.

National strategy for palliative care of severely ill and dying people and their relatives in pandemics (PallPan) in Germany - study protocol of a mixed-methods project
Bausewein C, Hodiamont F, Berges N, Ullrich A, Gerlach C, Oechsle K, Pauli B, Weber J, Stiel S, Schneider N, Krumm N, Rolke R, Jansky M, Nauck F, Wedding U, van Oorschot B, Roch C, Werner L, Fischer M, Schallenburger M, Reuters M, Schwartz J, Neukirchen M, Ates G, Maus K, Jaspers B, Radbruch L, Heckel M, Klinger I, Ostgathe C, Kriesen U, Junghanß C, Lehmann E, Gesell D, Gauder S, Boehlke C, Becker G, Pralong A, Strupp J, Leisse C, Schloesser K, Voltz R, Jung N, Simon S
BMC PALLIAT CARE. 2022;21(1):.

Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) - Part 1 with Recommendations on Epidemiology, Screening, Diagnostics and Therapy
Beckmann M, Stübs F, Koch M, Mallmann P, Dannecker C, Dietl A, Sevnina A, Mergel F, Lotz L, Hack C, Ehret A, Gantert D, Martignoni F, Cieslik J, Menke J, Ortmann O, Stromberger C, Oechsle K, Hornemann B, Mumm F, Grimm C, Sturdza A, Wight E, Loessl K, Golatta M, Hagen V, Dauelsberg T, Diel I, Münstedt K, Merz E, Vordermark D, Lindel K, Wittekind C, Küppers V, Lellé R, Neis K, Griesser H, Pöschel B, Steiner M, Freitag U, Gilster T, Schmittel A, Friedrich M, Haase H, Gebhardt M, Kiesel L, Reinhardt M, Kreißl M, Kloke M, Horn L, Wiedemann R, Marnitz S, Letsch A, Zraik I, Mangold B, Möckel J, Alt C, Wimberger P, Hillemanns P, Paradies K, Mustea A, Denschlag D, Henscher U, Tholen R, Wesselmann S, Fehm T
GEBURTSH FRAUENHEILK. 2022;82(2):139-180.

Looking back: Identifying supportive care and unmet needs of parents of children receiving specialist paediatric palliative care from the bereavement perspective
Bronsema A, Theißen T, Oechsle K, Wikert J, Escherich G, Rutkowski S, Bokemeyer C, Ullrich A
BMC PALLIAT CARE. 2022;21(1):.

Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) - Part 2 with Recommendations on Psycho-oncology, Rehabilitation, Follow-up, Recurrence, Palliative Therapy and Healthcare Facilities
Fehm T, Stübs F, Koch M, Mallmann P, Dannecker C, Dietl A, Sevnina A, Mergel F, Lotz L, Hack C, Ehret A, Gantert D, Martignoni F, Cieslik J, Menke J, Ortmann O, Stromberger C, Oechsle K, Hornemann B, Mumm F, Grimm C, Sturdza A, Wight E, Loessl K, Golatta M, Hagen V, Dauelsberg T, Diel I, Münstedt K, Merz E, Vordermark D, Lindel K, Wittekind C, Küppers V, Lellé R, Neis K, Griesser H, Pöschel B, Steiner M, Freitag U, Gilster T, Schmittel A, Friedrich M, Haase H, Gebhardt M, Kiesel L, Reinhardt M, Kreißl M, Kloke M, Horn L, Wiedemann R, Marnitz S, Letsch A, Zraik I, Mangold B, Möckel J, Alt C, Wimberger P, Hillemanns P, Paradies K, Mustea A, Denschlag D, Henscher U, Tholen R, Wesselmann S, Beckmann M
GEBURTSH FRAUENHEILK. 2022;82(2):181-205.

The Impact of the SARS-CoV-2 Pandemic on the Needs of Non-Infected Patients and Their Families in Palliative Care—Interviews with Those Concerned
Gerlach C, Ullrich A, Berges N, Bausewein C, Oechsle K, Hodiamont F
J CLIN MED. 2022;11(13):.

Effects of a communication training for oncologists on early addressing palliative and end-of-life care in advanced cancer care (PALLI-COM): a randomized, controlled trial
Harnischfeger N, Rath H, Alt-Epping B, Brand H, Haller K, Letsch A, Rieder N, Thuss-Patience P, Bokemeyer C, Bergelt C, Oechsle K
ESMO OPEN. 2022;7(6):.

Addressing palliative care and end-of-life issues in patients with advanced cancer: a systematic review of communication interventions for physicians not specialised in palliative care
Harnischfeger N, Rath H, Oechsle K, Bergelt C
BMJ OPEN. 2022;12(6):.

Dying in hospital in Germany - optimising care in the dying phase:study protocol for a multi-centre bottom-up intervention on ward level
Kremeike K, Ullrich A, Schulz H, Rosendahl C, Boström K, Kaur S, Oubaid N, Plathe-Ignatz C, Leminski C, Hower K, Pfaff H, Hellmich M, Oechsle K, Voltz R
BMC PALLIAT CARE. 2022;21:.

Preventing adverse events of chemotherapy for gastrointestinal cancer by educating patients about the nocebo effect: a randomized-controlled trial
Michnevich T, Pan Y, Hendi A, Oechsle K, Stein A, Nestoriuc Y
BMC CANCER. 2022;22(1):.

Die „ungehörten“ und „ungehörigen“ sorgenden Angehörigen
Oechsle K
Die Hospiz-Zeitschrift: Fachforum für palliative Care. 2022;24(4):25-30.

Specialized Outpatient Palliative Care-an Interim Assessment
Oechsle K
DTSCH ARZTEBL INT. 2022;119(18):325-326.

Den letzten Weg gemeinsam gehen: Angehörige in verschiedenen Sterbesettings
Oechsle K, Ullrich A
2022. Kontext Sterben. Caduff C, Afzali M, Müller F, Soom E (eds.). 1. ed. Zürich: Scheidegger & Spiess, 51-63.

Deutschsprachige Instrumente zur Bedarfserhebung bei Angehörigen: Eine narrative Übersicht über verfügbare Selbsteinschätzungsinstrumente zur Erfassung verschiedener Aspekte möglicher Angehörigenbedarfe
Oubaid N, Ullrich A, Schwenzitzki L, Berendt J, Heckel M, Hentschel L, Hornemann B, Jentschke E, Pauli B, Simon S, Stiel S, van Oorschot B, Oechsle K
ONKOLOGE. 2022;28:420-428.

First-line salvage treatment options for germ cell tumor patients failing stage-adapted primary treatment: A comprehensive review compiled by the German Testicular Cancer Study Group
Pfister D, Oechsle K, Schmidt S, Busch J, Bokemeyer C, Heidenreich A, Heinzelbecker J, Ruf C, Winter C, Zengerling F, Kliesch S, Albers P, Oing C
WORLD J UROL. 2022;40(12):2853-2861.

Testicular germ cell tumours' clinical stage I: comparison of surveillance with adjuvant treatment strategies regarding recurrence rates and overall survival-a systematic review
Ruf C, Schmidt S, Kliesch S, Oing C, Pfister D, Busch J, Heinzelbecker J, Winter C, Zengerling F, Albers P, Oechsle K, Krege S, Lackner J, Dieckmann K
WORLD J UROL. 2022;40(12):2889-2900.

What are the personal last wishes of people with a life-limiting illness?: Findings from a longitudinal observational study in specialist palliative care
Ullrich A, Hollburg W, Schulz H, Goldbach S, Rommel A, Müller M, Kirsch D, Kopplin-Foertsch K, Messerer J, König L, Schulz-Kindermann F, Bokemeyer C, Oechsle K
BMC PALLIAT CARE. 2022;21(1):38.

Acceptance and Benefits of Two Different Strategies to Timely Integrate Specialist Palliative Care into Routine Cancer Care - a Randomized Pilot Study
Ullrich A, Wilde S, Müller V, Sinn M, Gebhardt C, Velthaus J, Gerlach C, Bokemeyer C, Oechsle K
ONCOL RES TREAT. 2022;45(3):118-129.

How does spirituality manifest in family caregivers of terminally ill cancer patients? A qualitative secondary analysis
Wikert J, Treutlein M, Theochari M, Bokemeyer C, Oechsle K, Ullrich A
PALLIAT SUPPORT CARE. 2022;20(1):45-54.

Management of Germ Cell Tumours of the Testes in Adult Patients: German Clinical Practice Guideline, PART II - Recommendations for the Treatment of Advanced, Recurrent, and Refractory Disease and Extragonadal and Sex Cord/Stromal Tumours and for the Management of Follow-Up, Toxicity, Quality of Life, Palliative Care, and Supportive Therapy
Kliesch S, Schmidt S, Wilborn D, Aigner C, Albrecht W, Bedke J, Beintker M, Beyersdorff D, Bokemeyer C, Busch J, Classen J, de Wit M, Dieckmann K, Diemer T, Dieing A, Gockel M, Göckel-Beining B, Hakenberg O, Heidenreich A, Heinzelbecker J, Herkommer K, Hermanns T, Kaufmann S, Kornmann M, Kotzerke J, Krege S, Kristiansen G, Lorch A, Müller A, Oechsle K, Ohloff T, Oing C, Otto U, Pfister D, Pichler R, Recken H, Rick O, Rudolph Y, Ruf C, Schirren J, Schmelz H, Schmidberger H, Schrader M, Schweyer S, Seeling S, Souchon R, Winter C, Wittekind C, Zengerling F, Zermann D, Zillmann R, Albers P
UROL INT. 2021;105(3-4):181-191.

Management of Germ Cell Tumours of the Testis in Adult Patients. German Clinical Practice Guideline Part I: Epidemiology, Classification, Diagnosis, Prognosis, Fertility Preservation, and Treatment Recommendations for Localized Stages
Kliesch S, Schmidt S, Wilborn D, Aigner C, Albrecht W, Bedke J, Beintker M, Beyersdorff D, Bokemeyer C, Busch J, Classen J, de Wit M, Dieckmann K, Diemer T, Dieing A, Gockel M, Göckel-Beining B, Hakenberg O, Heidenreich A, Heinzelbecker J, Herkommer K, Hermanns T, Kaufmann S, Kornmann M, Kotzerke J, Krege S, Kristiansen G, Lorch A, Müller A, Oechsle K, Ohloff T, Oing C, Otto U, Pfister D, Pichler R, Recken H, Rick O, Rudolph Y, Ruf C, Schirren J, Schmelz H, Schmidberger H, Schrader M, Schweyer S, Seeling S, Souchon R, Winter C, Wittekind C, Zengerling F, Zermann D, Zillmann R, Albers P
UROL INT. 2021;105(3-4):169-180.

Mitbetreuung und Einbeziehung von Angehörigen in Comprehensive Cancer Centern – eine Erhebung der AG Palliativmedizin der von der Deutschen Krebshilfe geförderten Onkologischen Spitzenzentren
Oechsle K, Theißen T, Heckel M, Schwenzitzki L, Ullrich A, Ostgathe C
DEUT MED WOCHENSCHR. 2021;146(18):e74-e80.

Existential distress in patients with advanced cancer and their caregivers: study protocol of a longitudinal cohort study
Philipp R, Kalender A, Härter M, Bokemeyer C, Oechsle K, Koch-Gromus U, Vehling S
BMJ OPEN. 2021;11(4):.

Virtuelle Palliativversorgung: Pilotierung eines elektronischen Tools zur Prüfung kognitiver, psychomotorischer und affektiver palliativmedizinischer und schmerztherapeutischer Lerninhalte während der ärztlichen Ausbildung
Scherg A, Oechsle K, Coym A, Ilse B, Annweiler B, Alt-Epping B, Neukirchen M, Lemos M, Stummer T, Seibel J, Lenes A, Elsner F
SCHMERZ. 2021;35(4):242-250.

Gender-specific problems and needs of family caregivers during specialist inpatient palliative care: a qualitative study on experiences of family caregivers and healthcare professionals
Ullrich A, Eicken S, Coym A, Hlawatsch C, Bokemeyer C, Oechsle K
ANN PALLIAT MED. 2021;10(8):8571-8583.

Supportive care needs and service use during palliative care in family caregivers of patients with advanced cancer - a prospective longitudinal study
Ullrich A, Marx G, Bergelt C, Benze G, Zhang Y, Wowretzko F, Heine J, Dickel L, Nauck F, Bokemeyer C, Oechsle K
SUPPORT CARE CANCER. 2021;29(3):1303-1315.

Need for additional professional psychosocial and spiritual support in patients with advanced diseases in the course of specialist palliative care - a longitudinal observational study
Ullrich A, Schulz H, Goldbach S, Hollburg W, Rommel A, Müller M, Kirsch D, Kopplin-Förtsch K, Messerer J, König L, Schulz-Kindermann F, Bokemeyer C, Oechsle K
BMC PALLIAT CARE. 2021;20(1):182.

Thoughts of death and suicidality among patients with cancer: examining subtypes and their association with mental disorders
Vehling S, Mehnert-Theuerkauf A, Glaesmer H, Bokemeyer C, Oechsle K, Härter M, Koch-Gromus U
PSYCHO-ONCOLOGY. 2021;30(12):2023-2031.

Perceived Positive and Negative Life Changes in Testicular Cancer Survivors
Vehling S, Oechsle K, Hartmann M, Bokemeyer C, Mehnert-Theuerkauf A
MEDICINA-LITHUANIA. 2021;57(9):993.

Symptom Burden and Palliative Care Needs of Patients with Incurable Cancer at Diagnosis and During the Disease Course
Vogt J, Beyer F, Sistermanns J, Kuon J, Kahl C, Alt-Epping B, Stevens S, Ahlborn M, George C, Heider A, Tienken M, Loquai C, Stahlhut K, Ruellan A, Kubin T, Dietz A, Oechsle K, Mehnert-Theuerkauf A, van Oorschot B, Thomas M, Ortmann O, Engel C, Lordick F
ONCOLOGIST. 2021;26(6):e1058-e1065.

Kommunikationstraining für onkologisch tätige Ärtz*Innen in Deutschalnd
Wünsch A, Bergelt C, Götze H, Karger A, Oechsle K, Rüffer J, Speiser D, Vitinius F
Forum. Das offizielle Magazin der Deutschen Krebsgesellschaft e.V.. 2021;2021(36):391-395.

Kommunikationstrainings für onkologisch tätige Ärzt*innen in Deutschland
Wünsch A, Bergelt C, Götze H, Karger A, Oechsle K, Rüffer J, Speiser D, Vitinius F
Forum. Das offizielle Magazin der Deutschen Krebsgesellschaft e.V.. 2021;2021(5):.

Tipping point: When patients stop eating and drinking in the last phase of their life
Blum D, Jensen W, Ullrich A, Hlawatsch C, Bokemeyer C, Oechsle K
CLIN NUTR ESPEN. 2020;38:280-282.

Individual specialist physical activity assessment and intervention in advanced cancer patients on a palliative care ward; the 3STEPS-study
Blum D, Schuetz C, Jensen W, Wannke L, Ketels G, Bokemeyer C, Oechsle K
ANN PALLIAT MED. 2020;9(6):4315-4322.

Impact, challenges and limits of inpatient palliative care consultations - perspectives of requesting and conducting physicians
Coym A, Oechsle K, Kanitz A, Puls N, Blum D, Bokemeyer C, Ullrich A
BMC HEALTH SERV RES. 2020;20(1):86.

Systematic symptom and problem assessment at admission to the palliative care ward - perspectives and prognostic impacts
Coym A, Ullrich A, Hackspiel L, Ahrenholz M, Bokemeyer C, Oechsle K
BMC PALLIAT CARE. 2020;19(1):75.

Evaluation of a communication skills training to facilitate addressing palliative care related topics in advanced cancer patients: study protocol of a multicenter randomized controlled trial (PALLI-KOM)
Harnischfeger N, Rath H, Ullrich A, Alt-Epping B, Letsch A, Thuss-Patience P, Bokemeyer C, Oechsle K, Bergelt C
BMC PALLIAT CARE. 2020;19(1):67.

Standard Operating Procedures (SOPs) for Palliative Care in German Comprehensive Cancer Centers - an evaluation of the implementation status
Lödel S, Ostgathe C, Heckel M, Oechsle K, Gahr S
BMC PALLIAT CARE. 2020;19(1):62.

Efficacy of the Managing Cancer and Living Meaningfully (CALM) individual psychotherapy for patients with advanced cancer: A single-blind randomized controlled trial
Mehnert A, Koranyi S, Philipp R, Scheffold K, Kriston L, Lehmann-Laue A, Engelmann D, Vehling S, Eisenecker C, Oechsle K, Schulz-Kindermann F, Rodin G, Härter M
PSYCHO-ONCOLOGY. 2020;29(11):1895-1904.

Palliativmedizin
Oechsle K
2020. Taschenbuch Onkologie. Honecker F, Claßen J, Preiß J, Dornoff W (eds.). 20. ed. München: W. Zuckschwerdt Verlag, 272-278.

Schmerztherapie
Oechsle K
2020. Taschenbuch Onkologie. . Honecker F, Claßen J, Preiß J, Dornoff W (eds.). 20. ed. München: 264-268.

Prevalence and Predictors of Distress, Anxiety, Depression, and Quality of Life in Bereaved Family Caregivers of Patients With Advanced Cancer
Oechsle K, Ullrich A, Marx G, Benze G, Wowretzko F, Zhang Y, Dickel L, Heine J, Wendt K, Nauck F, Bokemeyer C, Bergelt C
AM J HOSP PALLIAT ME. 2020;37(3):201-213.

Assessing palliative care need in left ventricular assist device patients and heart transplant recipients
Strangl F, Ullrich A, Oechsle K, Bokemeyer C, Blankenberg S, Knappe-Wegner D, Reichenspurner H, Bernhardt A, Barten M, Rybczynski M
INTERACT CARDIOV TH. 2020;31(6):874-880.

Ethical challenges in family caregivers of patients with advanced cancer - a qualitative study
Ullrich A, Theochari M, Bergelt C, Marx G, Woellert K, Bokemeyer C, Oechsle K
BMC PALLIAT CARE. 2020;19(1):70.

Everolimus in patients with multiply relapsed or cisplatin refractory germ cell tumors: results of a phase II, single-arm, open-label multicenter trial (RADIT) of the German Testicular Cancer Study Group
Fenner M, Oing C, Dieing A, Gauler T, Oechsle K, Lorch A, Hentrich M, Kopp H, Bokemeyer C, Honecker F
J CANCER RES CLIN. 2019;145(3):717-723.

Specific challenges in end-of-life care for patients with hematological malignancies
Gerlach C, Alt-Epping B, Oechsle K
CURR OPIN SUPPORT PA. 2019;13(4):369-379.

Sterbephase: Palliative Sedierung
Goldbach S, Oechsle K
2019. FAQ Palliativmedizin. Oechsle K, Scherg A (eds.). 1. ed. München: Urban & Fischer, 153-160.

Challenges Faced by Prehospital Emergency Physicians Providing Emergency Care to Patients with Advanced Incurable Diseases
Kamphausen A, Roese H, Oechsle K, Issleib M, Zöllner C, Bokemeyer C, Ullrich A
EMERG MED INT. 2019;2019:3456471.

Current Advances in Palliative & Hospice Care: Problems and Needs of Relatives and Family Caregivers During Palliative and Hospice Care-An Overview of Current Literature
Oechsle K
Medical sciences (Basel, Switzerland). 2019;7(3):.

Die Bedeutung der Lebensqualität für Therapieentscheidungen am Lebensende
Oechsle K
Gynäkologische Praxis. 2019;(44):1-6.

Forschung in der Palliativversorgung in Deutschland: aktuelle Situation, Perspektiven und Grenzen?
Oechsle K
Z PALLIATMEDIZIN. 2019;2019(20):79 -88.

Frühe Integration von Palliativversorgung - was wirklich diskutiert werden sollte
Oechsle K
Karger Kompass Onkologie. 2019;(6):94-95.

Grundlagen: Prinzipien der Palliativmedizin
Oechsle K
2019. FAQ Palliativmedizin. Oechsle K, Scherg A (eds.). 1. ed. München: Urban & Fischer, 1-9.

Palliative Care in Patients with Hematological Malignancies
Oechsle K
ONCOL RES TREAT. 2019;42(1-2):25-30.

SOP - Akuter Verwirrtheitszustand
Oechsle K
ONKOLOGE. 2019;2018(24 (S1)):55 - 59.

Symptomkontrolle: Wunden und Blutungen
Oechsle K, Albert Y
2019. FAQ Palliativmedizin. Oechsle K, Scherg A (eds.). 1. ed. München: Urban & Fischer, 118-122.

Soziale Aspekte: Mitbetreuung der Angehörigen
Oechsle K, Hlawatsch C
2019. FAQ Palliativmedizin. Oechsle K, Scherg A (eds.). 1. ed. München: Urban & Fischer, 253-256.

Grundlagen: Was ist ein "Palliativpatient"
Oechsle K, Scherg A
2019. FAQ Palliativmedizin. Oechsle K, Scherg A (eds.). 1. ed. München: Urban & Fischer, 18-23.

Grundlagen: Angehörige
Oechsle K, Ullrich A
2019. FAQ Palliativmedizin. Oechsle K, Scherg A (eds.). 1. ed. München: Urban & Fischer, 24-28.

Trauerbegleitung: Begleitung trauernder Angehöriger
Oechsle K, Ullrich A
2019. FAQ Palliativmedizin. Oechsle K, Scherg A (eds.). 1. ed. München: Urban & Fischer, 165-170.

Psychological burden in family caregivers of patients with advanced cancer at initiation of specialist inpatient palliative care
Oechsle K, Ullrich A, Marx G, Benze G, Heine J, Dickel L, Zhang Y, Wowretzko F, Wendt K, Nauck F, Bokemeyer C, Bergelt C
BMC PALLIAT CARE. 2019;18(1):102.

Ethische und rechtliche Aspekte: Sterbehilfe
Scherg A, Oechsle K
2019. FAQ Palliativmedizin. Oechsle K, Scherg A (eds.). 1. ed. München: Urban & Fischer, 261-266.

Positronenemissionstomographie bei Keimzelltumoren des Mannes: Einsatzmöglichkeiten und Grenzen
Schriefer P, Hartmann M, Oechsle K, Meyer C, Klutmann S, Fisch M, Bokemeyer C, Oing C
UROLOGE. 2019;58(4):418-423.

The prognostic impact of different tumor marker levels in nonseminomatous germ cell tumor patients with intermediate prognosis: A registry of the International Global Germ Cell Tumor Collaborative Group (G3)
Seidel C, Daugaard G, Tryakin A, Necchi A, Cohn-Cedermark G, Ståhl O, Hentrich M, Brito M, Albany C, Taza F, Gerl A, Oechsle K, Oing C, Bokemeyer C
UROL ONCOL-SEMIN ORI. 2019;37(11):809.e19-809.e25.

Exploring the gender dimension of problems and needs of patients receiving specialist palliative care in a German palliative care unit - the perspectives of patients and healthcare professionals
Ullrich A, Grube K, Hlawatsch C, Bokemeyer C, Oechsle K
BMC PALLIAT CARE. 2019;18(1):59.

Palliativmedizin
Blatt-Bodewig M, Oechsle K
2018. Taschenbuch Onkologie. Honnecker F, Claßen J, Preiß J, Dornhoff W (eds.). 19. ed. München: W. Zuckschwerdt Verlag, 272-278.

Palliativmedizin
Distler L, Oechsle K
2018. Tachnbuch Onkologie. Honnecker , Claßen , Preiß , Dornhoff (eds.). 19. ed. W. Zuckschwerdt Verlag, .

Schmerztherapie
Distler L, Oechsle K
2018. Taschenbuch Onkologie. Honnecker F, Claßen J, Preiß J, Dornhoff W (eds.). 19. ed. München: W. Zuckschwerdt Verlag, 264-268.

Measuring the Psychosocial Dimensions of Quality of Life in Patients With Advanced Cancer
Grünke B, Philipp R, Vehling S, Scheffold K, Härter M, Oechsle K, Schulz-Kindermann F, Mehnert A, Lo C
J PAIN SYMPTOM MANAG. 2018;55(3):985-991.e1.

Kommentar II zum Fall: "Ethisch vertretbare Anwendung freiheitsentziehender Maßnahmen zur Durchführung einer Chemotherapie?
Oechsle K
ETHIK MED. 2018;2018(30):371 -373.

Palliativmedizin
Oechsle K
INTERNIST. 2018;59(9):921-933.

Palliativmedizinische Begleitung
Oechsle K
2018. Tumorerkrankungen der Vulva und Vagina. Schnürch H, Hampl M, Wölber L (eds.). 1. ed. Springer, 315-328.

Palliative treatment of germ cell cancer
Oing C, Giannatempo P, Honecker F, Oechsle K, Bokemeyer C, Beyer J
CANCER TREAT REV. 2018;71:102-107.

SOP - Umgang mit multiresistenten Erregern auf der Palliativstation
Ostgathe C, Stachura P, Hofmann S, van Oorschot B, Oechsle K, Bogdan C, Kunz B, Förtsch B, Klein C
ONKOLOGE. 2018;2018(24 (S1)):75 - 81.

Preventing adverse events of chemotherapy by educating patients about the nocebo effect (RENNO study) - study protocol of a randomized controlled trial with gastrointestinal cancer patients
Quidde J, Pan Y, Salm M, Hendi A, Nilsson S, Oechsle K, Stein A, Nestoriuc Y
BMC CANCER. 2018;18(1):916.

Intermediate prognosis in metastatic germ cell tumours-outcome and prognostic factors
Seidel C, Daugaard G, Tryakin A, Necchi A, Cohn Cedermark G, Ståhl O, Hentrich M, Brito M, Albany C, Taza F, Gerl A, Oechsle K, Bokemeyer C
EUR J CANCER. 2018;94:16-25.

The daily dynamics of loss orientation and life engagement in advanced cancer: A pilot study to characterise patterns of adaptation at the end of life
Vehling S, Gerstorf D, Schulz-Kindermann F, Oechsle K, Philipp R, Scheffold K, Härter M, Mehnert A, Lo C
EUR J CANCER CARE. 2018;27(4):e12842.

Corrigendum re: "Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours" [Eur Urol 2017;71:213-20]
Dieckmann K, Radtke A, Spiekermann M, Balks T, Matthies C, Becker P, Ruf C, Oing C, Oechsle K, Bokemeyer C, Hammel J, Melchior S, Wosniok W, Belge G
EUR UROL. 2017;71(5):e161.

Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours
Dieckmann K, Radtke A, Spiekermann M, Balks T, Matthies C, Becker P, Ruf C, Oing C, Oechsle K, Bokemeyer C, Hammel J, Melchior S, Wosniok W, Belge G
EUR UROL. 2017;71(2):213-220.

Retinal toxicity after cisplatin-based chemotherapy in patients with germ cell cancer
Dulz S, Asselborn N, Dieckmann K, Matthies C, Wagner W, Weidmann J, Seidel C, Oing C, Berger L, Alsdorf W, Mankichian B, Meyer C, Vetterlein M, Gild P, Ludwig T, Soave A, Schriefer P, Becker A, Ahyai S, Oechsle K, Bokemeyer C, Wagenfeld L, Fisch M, Hartmann M, Chun F, Kluth L
J CANCER RES CLIN. 2017;143(7):1319-1325.

Die Kommunikation schlechter Nachrichten bei Krebspatienten: Inhalte, Kommunikationspräferenzen und psychische Belastungen
Gebhardt C, Gorba C, Oechsle K, Vehling S, Koch-Gromus U, Mehnert A
PSYCHOTHER PSYCH MED. 2017;67(7):312-321.

Specific Characteristics of Patients with Advanced Genitourinary Cancer Receiving Specialized Inpatient Palliative Care
Iversen K, Oechsle K, Oing C, Bokemeyer C, Seidel C
ONCOL RES TREAT. 2017;40(10):609-614.

Self-assessment and Screening for palliative care need in patients with chronic heart failure
Oechsle K, Ehlert J, Kodolitsch Y, Ullrich A, Bokemeyer C, Rybczynski M
J PALLIAT CARE. 2017;2017(7):304.

Nachsorge, Fertilität, Langzeittoxizität und Survivorship bei Keimzelltumoren
Oechsle K, Krege S, Honecker F
ONKOLOGE. 2017;23(2):129-135.

Platinum-refractory germ cell tumors: an update on current treatment options and developments
Oing C, Alsdorf W, von Amsberg G, Oechsle K, Bokemeyer C
WORLD J UROL. 2017;35(8):1167-1175.

Impact of Primary Metastatic Bone Disease in Germ Cell Tumors: Results of an International Global Germ Cell Tumor Collaborative Group G3 Registry Study
Oing C, Oechsle K, Necchi A, Loriot Y, De Giorgi U, Fléchon A, Daugaard G, Fedyanin M, Faré E, Bokemeyer C
ANN ONCOL. 2017;28(3):576-582.

Attachment Insecurity in Advanced Cancer Patients: Psychometric Properties of the German Version of the Brief Experiences in Close Relationships Scale (ECR-M16-G)
Philipp R, Vehling S, Scheffold K, Grünke B, Härter M, Mehnert A, Oechsle K, Schulz-Kindermann F, Lo C
J PAIN SYMPTOM MANAG. 2017;54(4):555-562.

Quality of life, psychological burden, needs, and satisfaction during specialized inpatient palliative care in family caregivers of advanced cancer patients
Ullrich A, Ascherfeld L, Marx G, Bokemeyer C, Bergelt C, Oechsle K
BMC PALLIAT CARE. 2017;16(1):31.

Integrating patient reported measures as predictive parameters into decisionmaking about palliative chemotherapy: a pilot study
Creutzfeldt A, Suling A, Oechsle K, Mehnert A, Atanackovic D, Kripp M, Arnold D, Stein A, Quidde J
BMC PALLIAT CARE. 2016;15(1):25.

Cabazitaxel overcomes cisplatin resistance in germ cell tumour cells
Gerwing M, Jacobsen C, Dyshlovoy S, Hauschild J, Rohlfing T, Oing C, Venz S, Oldenburg J, Oechsle K, Bokemeyer C, von Amsberg G, Honecker F
J CANCER RES CLIN. 2016;142(9):1979-94.

Prospective Study on Music Therapy in Terminally Ill Cancer Patients during Specialized Inpatient Palliative Care
Kordovan S, Preissler P, Kamphausen A, Bokemeyer C, Oechsle K
J PALLIAT MED. 2016;19(4):394-9.

Prognostic impact of progression to induction chemotherapy and prior paclitaxel therapy in patients with germ cell tumors receiving salvage high-dose chemotherapy in the last 10 years: a study of the European Society for Blood and Marrow Transplantation Solid Tumors Working Party
Necchi A, Miceli R, Bregni M, Bokemeyer C, Berger L, Oechsle K, Schumacher K, Kanfer E, Bourhis J, Massard C, Laszlo D, Montoro J, Flechon A, Arpaci F, Secondino S, Wuchter P, Dreger P, Crysandt M, Worel N, Kruger W, Ringhoffer M, Unal A, Nagler A, Campos A, Wahlin A, Michieli M, Sucak G, Donnini I, Schots R, Ifrah N, Badoglio M, Martino M, Raggi D, Giannatempo P, Rosti G, Pedrazzoli P, Lanza F
BONE MARROW TRANSPL. 2016;51(3):384-90.

Palliativmedizinische Versorgung onkologischer Patienten
Oechsle K
2016. Handbuch Psychoonkologie. Mehnert A, Koch U (eds.). 1. ed. Hogrefe Verlag GmbH and Co. KG, 94-102.

Investigational targeted therapies for the treatment of testicular germ cell tumors
Oing C, Kollmannsberger C, Oechsle K, Bokemeyer C
EXPERT OPIN INV DRUG. 2016;25(9):1033-43.

Second Line Chemotherapy for Advanced and Metastatic Urothelial Carcinoma: Vinflunine and Beyond-A Comprehensive Review of the Current Literature
Oing C, Rink M, Oechsle K, Seidel C, von Amsberg G, Bokemeyer C
J UROLOGY. 2016;195(2):254-63.

Pharmacotherapeutic treatment of germ cell tumors - standard of care and recent developments
Oing C, Seidel C, von Amsberg G, Oechsle K, Bokemeyer C
EXPERT OPIN PHARMACO. 2016;17(4):545-60.

Detrimental social interactions predict loss of dignity among patients with cancer
Philipp R, Mehnert A, Lehmann C, Oechsle K, Bokemeyer C, Krüll A, Vehling S
SUPPORT CARE CANCER. 2016;24(6):2751-8.

Musiktherapie auf der Palliativstation: Ergebnisse einer Studie über ein musiktherapeutisches Angebot
Preißler P, Kordovan S, Bokemeyer C, Oechsle K
Musiktherapeutische Umschau. 2016;37(3):233-249.

Favored subjects and psychosocial needs in music therapy in terminally ill cancer patients: a content analysis
Preissler P, Kordovan S, Ullrich A, Bokemeyer C, Oechsle K
BMC PALLIAT CARE. 2016;15:48.

Efficacy and safety of gemcitabine, oxaliplatin, and paclitaxel in cisplatin-refractory germ cell cancer in routine care-Registry data from an outcomes research project of the German Testicular Cancer Study Group
Seidel C, Oechsle K, Lorch A, Dieing A, Hentrich M, Hornig M, Grünwald V, Cathomas R, Meiler J, de Wit M, Bokemeyer C
UROL ONCOL-SEMIN ORI. 2016;34(4):167.e21-8.

Die Mitteilung schlechter Nachrichten durch den Arzt: Die deutsche Version des MPP- (Measure of Patients' Preferences) Fragebogens zu den kommunikativen Präferenzen von Krebspatienten
Ernst J, Friedrich M, Lehmann C, Vehling S, Oechsle K, Koch-Gromus U, Mehnert A
GESUNDHEITSWESEN. 2015.

Age-related variation and predictors of long-term quality of life in germ cell tumor survivors
Hartung T, Mehnert A, Friedrich M, Hartmann M, Vehling S, Bokemeyer C, Oechsle K
UROL ONCOL-SEMIN ORI. 2015.

Regulation of tissue factor in NT2 germ cell tumor cells by cisplatin chemotherapy
Jacobsen C, Oechsle K, Hauschild J, Steinemann G, Spath B, Bokemeyer C, Ruf W, Honecker F, Langer F
THROMB RES. 2015;136(3):673-81.

Symptom burden in long-term germ cell tumor survivors
Oechsle K, Hartmann M, Mehnert A, Oing C, Bokemeyer C, Vehling S
SUPPORT CARE CANCER. 2015.

First salvage treatment of germ cell tumor patients with bone metastases: retrospective analysis of a large international database
Oing C, Lorch A, Bokemeyer C, Honecker F, Beyer J, Berger L, Oechsle K
J CANCER RES CLIN. 2015;141(5):923-31.

Efficacy of a brief manualized intervention Managing Cancer and Living Meaningfully (CALM) adapted to German cancer care settings: study protocol for a randomized controlled trial
Scheffold K, Philipp R, Engelmann D, Schulz-Kindermann F, Rosenberger C, Oechsle K, Härter M, Wegscheider K, Lordick F, Lo C, Hales S, Rodin G, Mehnert A
BMC CANCER. 2015;15:592.

Integration von palliativmedizinischer Betreuung – Ist früher besser?
Schmitz M, Bokemeyer C, Oechsle K
ONKOLOGE. 2015;21(1):848-851.

Needs, symptoms, and outcome of patients with advanced head and neck cancer treated on a palliative care inpatient ward
Schmitz M, Wolfram M, Bokemeyer C, Oechsle K
2015. Gemeinsame Jahrestagung, Basel, Oktober 2015: Abstracts. .

The Preference to Discuss Expected Survival Is Associated with Loss of Meaning and Purpose in Terminally Ill Cancer Patients
Vehling S, Kamphausen A, Oechsle K, Hroch S, Bokemeyer C, Mehnert A
J PALLIAT MED. 2015;18(11):970-976.

Anxiety and depression in long-term testicular germ cell tumor survivors
Vehling S, Mehnert A, Hartmann M, Oing C, Bokemeyer C, Oechsle K
GEN HOSP PSYCHIAT. 2015.

First salvage treatment in patients with advanced germ cell cancer after cisplatin-based chemotherapy: analysis of a registry of the German Testicular Cancer Study Group (GTCSG)
Berger L, Bokemeyer C, Lorch A, Hentrich M, Kopp H, Gauler T, Beyer J, de Wit M, Mayer F, Boehlke I, Oing C, Honecker F, Oechsle K
J CANCER RES CLIN. 2014;140(7):1211-1220.

Exercise training in patients with advanced gastrointestinal cancer undergoing palliative chemotherapy: a pilot study
Jensen W, Baumann F, Stein A, Bloch W, Bokemeyer C, de Wit M, Oechsle K
SUPPORT CARE CANCER. 2014;22(7):1797-806.

Physical exercise and therapy in terminally ill cancer patients: a retrospective feasibility analysis
Jensen W, Bialy L, Ketels G, Baumann F, Bokemeyer C, Oechsle K
SUPPORT CARE CANCER. 2014;22(5):1261-8.

Effects of exercise training programs on physical performance and quality of life in patients with metastatic lung cancer undergoing palliative chemotherapy--a study protocol
Jensen W, Oechsle K, Baumann H, Mehnert A, Klose H, Bloch W, Bokemeyer C, Baumann F
CONTEMP CLIN TRIALS. 2014;37(1):120-8.

Multimodal exercise training during myeloablative chemotherapy: a prospective randomized pilot trial
Oechsle K, Aslan Z, Suesse Y, Jensen W, Bokemeyer C, de Wit M
SUPPORT CARE CANCER. 2014;22(1):63-9.

Relationship Between Symptom Burden, Distress, and Sense of Dignity in Terminally Ill Cancer Patients
Oechsle K, Wais M, Vehling S, Bokemeyer C, Mehnert A
J PAIN SYMPTOM MANAG. 2014.

Testicular Germ Cell Tumors
Oing C, Bokemeyer C, Oechsle K
2014. Nuclear Oncology. 1. ed. Philadelphia, PA 19103 USA: Wolters Kluwer, 241-250.

Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer.
Beyer J, Albers P, Altena R, Aparicio J, Bokemeyer C, Busch J, Cathomas R, Cavallin-Stahl E, Clarke N, Claßen J, Cohn-Cedermark G, Dahl A, Daugaard G, De Giorgi U, De Santis M, De Wit M, De Wit R, Dieckmann K, Fenner M, Fizazi K, Flechon A, Fossa S, Germá Lluch J, Gietema J, Gillessen S, Giwercman A, Hartmann J, Heidenreich A, Hentrich M, Honecker F, Horwich A, Huddart R, Kliesch S, Kollmannsberger C, Krege S, Laguna M, Looijenga L, Lorch A, Lotz J, Mayer F, Necchi A, Nicolai N, Nuver J, Oechsle K, Oldenburg J, Oosterhuis J, Powles T, Rajpert-De Meyts E, Rick O, Rosti G, Salvioni R, Schrader M, Schweyer S, Sedlmayer F, Sohaib A, Souchon R, Tandstad T, Winter C, Wittekind C
ANN ONCOL. 2013;24(4):878-888.

Tumore des Urogenitaltrakts
Bokemeyer C, Oechsle K, Oing C
2013. OnkoUpDate. Wiesbaden: med publico GmbH, .

Venous thromboembolic events in germ cell cancer patients undergoing platinum-based chemotherapy
Honecker F, Koychev D, Lühmann A, Langer F, Dieckmann K, Bokemeyer C, Oechsle K
ONKOLOGIE. 2013;36(11):663-8.

Anxiety and depression in caregivers of terminally ill cancer patients: impact on their perspective of the patients' symptom burden
Oechsle K, Goerth K, Bokemeyer C, Mehnert A
J PALLIAT MED. 2013;16(9):1095-101.

Symptom burden in palliative care patients: perspectives of patients, their family caregivers, and their attending physicians
Oechsle K, Görth K, Bokemeyer C, Mehnert A
SUPPORT CARE CANCER. 2013;21(7):1955-62.

Spättoxizität und Survivorship bei Keimzelltumoren
Oechsle K, Schilling G, Oing C, Bokemeyer C
ONKOLOGE. 2013;19(7):573-581.

Receiving palliative treatment moderates the effect of age and gender on demoralization in patients with cancer
Vehling S, Oechsle K, Koch-Gromus U, Mehnert A
PLOS ONE. 2013;8(3):e59417.

2-¹⁸fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial.
Bachner M, Loriot Y, Gross-Goupil M, Zucali P, Horwich A, Germa-Lluch J, Kollmannsberger C, Stoiber F, Fléchon A, Oechsle K, Gillessen S, Oldenburg J, Cohn-Cedermark G, Daugaard G, Morelli F, Sella A, Harland S, Kerst M, Gampe J, Dittrich C, Fizazi K, De Santis M
ANN ONCOL. 2012;23(1):59-64.

Gastrointestinale Tumore
Jensen W, Oechsle K
2012. Sport und körperliche Aktivität in der Onkologie. Springer Verlag Berlin Heidelberg: 155-166.

Bone metastases in germ cell tumor patients.
Oechsle K, Bokemeyer C, Kollmannsberger C, Mayer F, Berger L, Oing C, Honecker F
J CANCER RES CLIN. 2012;138(6):947-952.

Integrierte onkologische und palliativmedizinische Patientenbetreuung
Oechsle K, Schilling G
Forum. Das offizielle Magazin der Deutschen Krebsgesellschaft e.V.. 2012;27(5):354.

Is advanced cancer associated with demoralization and lower global meaning? The role of tumor stage and physical problems in explaining existential distress in cancer patients.
Vehling S, Lehmann C, Oechsle K, Bokemeyer C, Krüll A, Koch-Gromus U, Mehnert A
PSYCHO-ONCOLOGY. 2012;21(1):54-63.

Treatment of patients with relapsed and/or cisplatin-refractory metastatic germ cell tumours: an update.
Koychev D, Oechsle K, Bokemeyer C, Honecker F
INT J ANDROL. 2011;34(4 Pt 2):266-273.

Treatment of brain metastases from germ cell tumors.
Oechsle K, Bokemeyer C
HEMATOL ONCOL CLIN N. 2011;25(3):605-613.

Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: a Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative study
Oechsle K, Honecker F, Cheng T, Mayer F, Czaykowski P, Winquist E, Wood L, Fenner M, Glaesener S, Hartmann J, Chi K, Bokemeyer C, Kollmannsberger C
ANN ONCOL. 2011;22(12):2654-60.

Physical activity, quality of life, and the interest in physical exercise programs in patients undergoing palliative chemotherapy.
Oechsle K, Jensen W, Schmidt T, Reer R, Braumann K, De Wit M, Bokemeyer C
SUPPORT CARE CANCER. 2011;19(5):613-619.

Long-term survival after treatment with gemcitabine and oxaliplatin with and without paclitaxel plus secondary surgery in patients with cisplatin-refractory and/or multiply relapsed germ cell tumors.
Oechsle K, Kollmannsberger C, Honecker F, Mayer F, Waller C, Hartmann J, Boehlke I, Bokemeyer C, Group G
EUR UROL. 2011;60(4):850-855.

Global meaning and meaning-related life attitudes: exploring their role in predicting depression, anxiety, and demoralization in cancer patients.
Vehling S, Lehmann C, Oechsle K, Bokemeyer C, Krüll A, Koch-Gromus U, Mehnert A
SUPPORT CARE CANCER. 2011;19(4):513-520.

Keimzelltumore des Hodens
Oechsle K
2010. Therapiealgorithmen Onkologie. rs media GmbH: .

Organprotektion in der Tumortherapie - mit Medikamenten vor unerwünschten Wirkungen schützen
Oechsle K, Bokemeyer C
Im Fokus Onkologie. 2010;12:43-47.

Unterschätztes Risiko - Kardiotoxizität onkologischer Therapien
Oechsle K, Bokemeyer C
Im Fokus Onkologie. 2010;7(8):49-53.

Erratum to: Lenalidomide in patients with cisplatin-refractory and multiply relapsed germ cell tumors.
Oechsle K, Bokemeyer C, Honecker F
J CANCER RES CLIN. 2010;136(1):169.

Lenalidomide in patients with cisplatin-refractory and multiply relapsed germ cell tumors.
Oechsle K, Bokemeyer C, Honecker F
J CANCER RES CLIN. 2010;136(1):165-167.

Prognostic factors and treatment options in patients with leptomeningeal metastases of different primary tumors: a retrospective analysis.
Oechsle K, Lange-Brock V, Krüll A, Bokemeyer C, De Wit M
J CANCER RES CLIN. 2010;136(11):1729-1735.

Patterns of relapse after chemotherapy in patients with high-risk non-seminomatous germ cell tumor.
Oechsle K, Lorch A, Honecker F, Kollmannsberger C, Hartmann J, Boehlke I, Beyer J, Bokemeyer C
ONCOLOGY-BASEL. 2010;78(1):47-53.

Microsatellite instability, mismatch repair deficiency, and BRAF mutation in treatment-resistant germ cell tumors.
Honecker F, Wermann H, Mayer F, Gillis A, Stoop H, Gurp v, Oechsle K, Oechsle K, Steyerberg E, Hartmann J, Dinjens W, Bokemeyer C, Bokemeyer C, Looijenga L
J CLIN ONCOL. 2009;27(13):2129-2136.

Intraperitoneal VEGF inhibition using bevacizumab: a potential approach for the symptomatic treatment of malignant ascites?
Kobold S, Hegewisch-Becker S, Oechsle K, Jordan K, Bokemeyer C, Atanackovic D
ONCOLOGIST. 2009;14(12):1242-1251.

[Salvage treatment in germ cell tumors : high-dose chemotherapy and the impact of prognostic factors]
Lorch A, Oechsle K, Bokemeyer C, Beyer J
UROLOGE. 2009;48(4):364-371.

Chemotherapie-induzierte Kardiotoxizität
Oechsle K, Bokemeyer C
2009. Supportivtherapie in der Onkologie. Urban & Vogel: 62-71.

Kardiotoxizitäten bei Chemo-Radiotherapie
Oechsle K, Bokemeyer C
ONKOLOGE. 2009;15:157-162.

Four consecutive multicenter phase II trials of adjuvant chemoradiation in patients with completely resected high-risk gastric cancer: the experience of the German AIO/ARO/CAO group.
Oechsle K, Bokemeyer C, Hartmann J, Budach W, Trarbach T, Stahl M, Boehlke I, Kollmannsberger C
J CANCER RES CLIN. 2009;135(2):163-172.

Molecular determinants of response to matuzumab in combination with paclitaxel for patients with advanced non-small cell lung cancer.
Schittenhelm M, Kollmannsberger C, Oechsle K, Harlow A, Morich J, Honecker F, Kurek R, Störkel S, Kanz L, Corless C, Wong K, Bokemeyer C, Heinrich M
MOL CANCER THER. 2009;8(3):481-489.

Combination chemotherapy with gemcitabine, oxaliplatin, and paclitaxel in patients with cisplatin-refractory or multiply relapsed germ-cell tumors: a study of the German Testicular Cancer Study Group.
Bokemeyer C, Oechsle K, Honecker F, Mayer F, Hartmann J, Waller C, Böhlke I, Kollmannsberger C
ANN ONCOL. 2008;19(3):448-453.

[18F]Fluorodeoxyglucose positron emission tomography in nonseminomatous germ cell tumors after chemotherapy: the German multicenter positron emission tomography study group.
Oechsle K, Hartmann M, Brenner W, Venz S, Weissbach L, Franzius C, Kliesch S, Mueller S, Krege S, Heicappell R, Bares R, Bokemeyer C, De Wit M
J CLIN ONCOL. 2008;26(36):5930-5935.

Cerebral metastases in non-seminomatous germ cell tumour patients undergoing primary high-dose chemotherapy.
Oechsle K, Kollmannsberger C, Honecker F, Boehlke I, Bokemeyer C
EUR J CANCER. 2008;44(12):1663-1669.

An open label, non-comparative phase II study of gemcitabine as salvage treatment for patients with pretreated adult type soft tissue sarcoma
Hartmann J, Oechsle K, Huober J, Jakob A, Azemar M, Horger M, Kanz L, Bokemeyer C
INVEST NEW DRUG. 2006;24(3):249-53.

Disseminated mucormycosis in haematological patients: CT and MRI findings with pathological correlation
Horger M, Hebart H, Schimmel H, Vogel M, Brodoefel H, Oechsle K, Hahn U, Mittelbronn M, Bethge W, Claussen C
BRIT J RADIOL. 2006;79(945):e88-95.

A phase I study of the humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody EMD 72000 (matuzumab) in combination with paclitaxel in patients with EGFR-positive advanced non-small-cell lung cancer (NSCLC)
Kollmannsberger C, Schittenhelm M, Honecker F, Tillner J, Weber D, Oechsle K, Kanz L, Bokemeyer C
ANN ONCOL. 2006;17(6):1007-13.

Aprepitant as salvage therapy in patients with chemotherapy-induced nausea and emesis refractory to prophylaxis with 5-HT(3) antagonists and dexamethasone
Oechsle K, Müller M, Hartmann J, Kanz L, Bokemeyer C
ONKOLOGIE. 2006;29(12):557-61.

Anaemia in cancer patients: pathophysiology, incidence and treatment
Bokemeyer C, Oechsle K, Hartmann J
EUR J CLIN INVEST. 2005;35 Suppl 3:26-31.

Role of postchemotherapy surgery in the management of patients with liver metastases from germ cell tumors
Hartmann J, Rick O, Oechsle K, Kuczyk M, Gauler T, Schöffski P, Schleicher J, Mayer F, Teichmann R, Kanz L, Bokemeyer C
ANN SURG. 2005;242(2):260-6.

Adjuvant chemoradiation using 5-fluorouracil/folinic acid/cisplatin with or without paclitaxel and radiation in patients with completely resected high-risk gastric cancer: two cooperative phase II studies of the AIO/ARO/ACO
Kollmannsberger C, Budach W, Stahl M, Schleucher N, Hehr T, Wilke H, Schleicher J, Vanhoefer U, Jehle E, Oechsle K, Trarbach T, Boehlke I, Kanz L, Hartmann J, Bokemeyer C
ANN ONCOL. 2005;16(8):1326-33.

2-18fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: an update of the prospective multicentric SEMPET trial
De Santis M, Becherer A, Bokemeyer C, Stoiber F, Oechsle K, Sellner F, Lang A, Kletter K, Dohmen B, Dittrich C, Pont J
J CLIN ONCOL. 2004;22(6):1034-9.

Prospective multicenter phase II study of irinotecan as third-line therapy in metastatic colorectal cancer and progression after bolus and infusional 5-fluorouracil
Hartmann J, Oechsle K, Jäger E, Reis H, Haag C, Niederle N, Wilke H, Pflüger K, Batran S, Büchele T, Hofheinz R, Kanz L, Bokemeyer C
ANTI-CANCER DRUG. 2004;15(5):473-7.

Capecitabine in combination with mitomycin C in patients with gastrointestinal cancer: results of an extended multicentre phase-I trial
Hofheinz R, Hartmann J, Willer A, Oechsle K, Hartung G, Gnad U, Saussele S, Kreil S, Bokemeyer C, Hehlmann R, Hochhaus A
BRIT J CANCER. 2004;91(5):834-8.

The role of [(18)F] FDG-PET, CT/MRI and tumor marker kinetics in the evaluation of post chemotherapy residual masses in metastatic germ cell tumors--prospects for management
Pfannenberg A, Oechsle K, Bokemeyer C, Kollmannsberger C, Dohmen B, Bares R, Hartmann J, Vonthein R, Claussen C
WORLD J UROL. 2004;22(2):132-9.

[ ¹⁸F]FDG-PET, CT/MRT und Tumormarker als prädiktive Indikatoren für das Ansprechen unter Hochdosis-Chemotherapie bei Patienten mit metastasierten Keimzelltumoren
Pfannenberg A, Oechsle K, Kollmannsberger C, Dohmen B, Bokemeyer C, Bares R, Vontheim R, Claussen C
ROFO-FORTSCHR RONTG. 2004;176(1):76-84.

Phase II trial of trofosfamide in patients with advanced pretreated soft tissue sarcomas
Hartmann J, Oechsle K, Mayer F, Kanz L, Bokemeyer C
ANTICANCER RES. 2003;23(2C):1899-901.

Protracted infusional 5-fluorouracil plus high-dose folinic acid combined with bolus mitomycin C in patients with gastrointestinal cancer: a phase I/II dose escalation study
Hartmann J, Oechsle K, Quietzsch D, Wein A, Hofheinz R, Honecker F, Nehls O, Köhne C, Käfer G, Kanz L, Bokemeyer C
BRIT J CANCER. 2003;89(11):2051-6.

An open label, non-comparative phase II study of topotecan as salvage treatment for patients with soft tissue sarcoma
Reichardt P, Oechsle K, Pink D, Bokemeyer C, Schneller F, Issels R, Kanz L, Hartmann J
INVEST NEW DRUG. 2003;21(4):481-6.

Early prediction of treatment response to high-dose salvage chemotherapy in patients with relapsed germ cell cancer using [(18)F]FDG PET
Bokemeyer C, Kollmannsberger C, Oechsle K, Dohmen B, Pfannenberg A, Claussen C, Bares R, Kanz L
BRIT J CANCER. 2002;86(4):506-11.

Treatment-induced anaemia and its potential clinical impact in patients receiving sequential high dose chemotherapy for metastatic testicular cancer
Bokemeyer C, Oechsle K, Hartmann J, Schöffski P, Schleucher N, Metzner B, Schleicher J, Kanz L
BRIT J CANCER. 2002;87(10):1066-71.

Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography with conventional assessment by computed tomography scans and serum tumor markers for the evaluation of residual masses in patients with nonseminomatous germ cell carcinoma
Kollmannsberger C, Oechsle K, Dohmen B, Pfannenberg A, Bares R, Claussen C, Kanz L, Bokemeyer C
CANCER-AM CANCER SOC. 2002;94(9):2353-62.

Predictive impact of 2-18fluoro-2-deoxy-D-glucose positron emission tomography for residual postchemotherapy masses in patients with bulky seminoma
De Santis M, Bokemeyer C, Becherer A, Stoiber F, Oechsle K, Kletter K, Dohmen B, Dittrich C, Pont J
J CLIN ONCOL. 2001;19(17):3740-4.

Letzte Aktualisierung aus dem FIS: 23.11.2024 - 03:43 Uhr